Debio 0123, a highly selective WEE1 inhibitor in adult patients with advanced solid tumors: A phase 1 dose escalation and expansion monotherapy study.

Authors: Maria M. Rubinstein, Manish R. Sharma, Kyriakos P. Papadopoulos, Maria-Pilar Barretina-Ginesta, Carmen García-Duran, Mariano Ponz-Sarvise, Andres Redondo, Victor Moreno, Denise S. Uyar, Julian Wampfler, Dagmar Hess, Luis Manso, Jeannette Fuchs, Emmelyne Dessein Corne, Noemie Luong, Vito Dozio, Tri Tat, Francoise Crevel, Victor Rodriguez Freixinos, Anastasios Stathis

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.tps5634

Source: Full article

---

Abstract

TPS5634